Cerebrospinal fluid neurogranin in Alzheimer's disease studies: are immunoassay results interchangeable?

Autor: Aveneau C; Centre de Neurologie Cognitive, GHU AP-HP Nord, Hôpital Lariboisière Fernand-Widal, Université de Paris, Paris, France., Hourregue C; Centre de Neurologie Cognitive, GHU AP-HP Nord, Hôpital Lariboisière Fernand-Widal, Université de Paris, Paris, France., Cognat E; Centre de Neurologie Cognitive, GHU AP-HP Nord, Hôpital Lariboisière Fernand-Widal, Université de Paris, Paris, France., Dumurgier J; Centre de Neurologie Cognitive, GHU AP-HP Nord, Hôpital Lariboisière Fernand-Widal, Université de Paris, Paris, France., Vanderstichele H; ADx NeuroSciences, Gent, Belgium., Vanmechelen E; ADx NeuroSciences, Gent, Belgium., Zetterberg H; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden., Hugon J; Centre de Neurologie Cognitive, GHU AP-HP Nord, Hôpital Lariboisière Fernand-Widal, Université de Paris, Paris, France., Blennow K; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden., Paquet C; Centre de Neurologie Cognitive, GHU AP-HP Nord, Hôpital Lariboisière Fernand-Widal, Université de Paris, Paris, France., Bouaziz-Amar E; Département de Biochimie, Université de Paris, GHU AP-HP Nord, Hôpital Lariboisière Fernand-Widal, Paris, France.
Jazyk: angličtina
Zdroj: Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2021 Sep 15; Vol. 60 (1), pp. e13-e17. Date of Electronic Publication: 2021 Sep 15 (Print Publication: 2022).
DOI: 10.1515/cclm-2021-0505
Databáze: MEDLINE